Stocks are mixed Wednesday as Wall Street focused on economic data that points to rising inflation as the Iran war drags on.

Defense contractor Anduril, which is helping build President Trump’s “Golden Dome” antimissile shield, completed a funding ...

BeOne Medicines received accelerated approval from the Food and Drug Administration for Beqalzi, a treatment aimed at certain lymphoma patients. The oncology company said Wednesday the treatment got ...

Mak Acquisition said it is in talks for a potential acquisition. The special purpose acquisition company said Wednesday it was responding to recent media reports speculating on a potential qualifying ...

Shares of closed-end fund Destiny Tech100 have been whipsawed this week, reflecting the promise and peril of trying to access ...

Tech stocks were back in the driver's seat again on Wednesday after a brief pause in their blistering rally from March's lows ...

In its monthly report, OPEC forecast global oil-demand growth of 1.17 million b/d this year, down from 1.38 million in its previous estimate made in mid-April. Next year's growth is projected at 1.54 ...

Inflation concerns clearly have been showing up in the U.S. bond market. The 10-year Treasury yield — a starting point to ...

A subsidiary of Zydus Lifesciences agreed to acquire pharmaceutical company Assertio Holdings for $166.4 million, topping Assertio's previous sale agreement with Garda Therapeutics.

Hydro One's board declared a dividend for the quarter of C$0.3531, payable June 30 to shareholders of record on June 10. The new payout, equal to about C$1.41 a year, represents an annual yield of ...

MarketWatch Picks highlights items we think you’ll find useful; we are independent of the MarketWatch newsroom. We earn a ...

Stocks were trading lower on Tuesday as investors digested inflation data and watched for updates on the Iran war ...